rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2008-11-17
|
pubmed:abstractText |
(1) To evaluate the efficacy of the Toxoplasma gondii screening program among Nunavik pregnant women in identifying seroconversions during pregnancy and performing an appropriate follow-up of the seroconverted women and their child; and (2) to evaluate the consequences of congenital Toxoplasma gondii infection.
|
pubmed:language |
fre
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0008-4263
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
99
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
397-400
|
pubmed:meshHeading |
pubmed-meshheading:19009924-Canada,
pubmed-meshheading:19009924-Female,
pubmed-meshheading:19009924-Humans,
pubmed-meshheading:19009924-Infant, Newborn,
pubmed-meshheading:19009924-Mass Screening,
pubmed-meshheading:19009924-Pregnancy,
pubmed-meshheading:19009924-Pregnancy Complications, Parasitic,
pubmed-meshheading:19009924-Program Evaluation,
pubmed-meshheading:19009924-Serologic Tests,
pubmed-meshheading:19009924-Time Factors,
pubmed-meshheading:19009924-Toxoplasmosis,
pubmed-meshheading:19009924-Toxoplasmosis, Congenital
|
pubmed:articleTitle |
[Evaluation of the efficacy of the Toxoplasma gondii screening program among pregnant women in Nunavik, 1994-2003].
|
pubmed:affiliation |
Unité de recherche en santé publique, Centre de Recherche du CHUL, Québec.
|
pubmed:publicationType |
Journal Article,
English Abstract
|